Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review.
Alnefeesi Y, Siegel A, Lui LMW, Teopiz KM, Ho RCM, Lee Y, Nasri F, Gill H, Lin K, Cao B, Rosenblat JD, McIntyre RS. Alnefeesi Y, et al. Front Psychiatry. 2021 Feb 10;11:621773. doi: 10.3389/fpsyt.2020.621773. eCollection 2020. Front Psychiatry. 2021. PMID: 33643083 Free PMC article.
Olanzapine and samidorphan combination treatment: A systematic review.
Jawad MY, Alnefeesi Y, Lui LMW, Ceban F, Chen-Li DCJ, Teopiz K, Jaberi S, Gillissie ES, Vincenzo JDD, Rosenblat JD, McIntyre RS. Jawad MY, et al. Among authors: alnefeesi y. J Affect Disord. 2022 Mar 15;301:99-106. doi: 10.1016/j.jad.2022.01.004. Epub 2022 Jan 7. J Affect Disord. 2022. PMID: 35007644 Review.
Corrigendum to "Olanzapine and samidorphan combination treatment: A systematic review". Journal of Affective Disorders. Volume 301, 15 March 2022, Pages 99-106.
Jawad MY, Alnefeesi Y, Lui LMW, Ceban F, Chen-Li DCJ, Teopiz K, Jaberi S, Gillissie ES, Di Vincenzo JD, Rosenblat JD, McIntyre RS. Jawad MY, et al. Among authors: alnefeesi y. J Affect Disord. 2022 May 1;304:167. doi: 10.1016/j.jad.2022.02.010. Epub 2022 Feb 16. J Affect Disord. 2022. PMID: 35181148 No abstract available.
Lumateperone for the Treatment of Adults With Schizophrenia: a Systematic Review.
Jawad MY, Alnefeesi Y, Ceban F, Lui LMW, Jaberi S, Di Vincenzo JD, Amirbeik L, Chen-Li DCJ, Teopiz K, Phan L, Cao B, Ho R, Rosenblat JD, McIntyre RS. Jawad MY, et al. Among authors: alnefeesi y. Curr Psychiatry Rep. 2022 Aug;24(8):359-368. doi: 10.1007/s11920-022-01344-1. Epub 2022 Jul 8. Curr Psychiatry Rep. 2022. PMID: 35802228 Review.
Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis.
Meshkat S, Alnefeesi Y, Jawad MY, D Di Vincenzo J, B Rodrigues N, Ceban F, Mw Lui L, McIntyre RS, Rosenblat JD. Meshkat S, et al. Among authors: alnefeesi y. Psychiatry Res. 2022 Nov;317:114857. doi: 10.1016/j.psychres.2022.114857. Epub 2022 Sep 21. Psychiatry Res. 2022. PMID: 36194941 Review.
Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trials.
Le GH, Gillissie ES, Rhee TG, Cao B, Alnefeesi Y, Guo Z, Di Vincenzo JD, Jawad MY, March AM, Ramachandra R, Lui LMW, McIntyre RS. Le GH, et al. Among authors: alnefeesi y. Expert Opin Investig Drugs. 2023 May;32(5):401-415. doi: 10.1080/13543784.2023.2206559. Epub 2023 May 1. Expert Opin Investig Drugs. 2023. PMID: 37096491